Haemonetics | HAE - Cash And Equivalent


Haemonetics reported $245.44M in Cash and Equivalent for its fiscal quarter ending in March of 2026.





Cash And Equivalent Change Date
Avanos Medical USD 65.6M 24.2M Mar/2026
Baxter International USD 2.02B 51M Mar/2026
Becton, Dickinson and Co. USD 813M 73M Mar/2026
Boston Scientific USD 1.45B 512M Mar/2026
Cerus USD 19.96M 4.29M Dec/2025
Cooper Companies USD 124.9M 14.3M Dec/2025
Fresenius EUR 1.31B 81M Dec/2025
Fresenius Medical Care EUR 1.24B 343.37M Mar/2026
Globus Medical USD 560.95M 34.79M Mar/2026
Haemonetics USD 245.44M 117.93M Mar/2026
ICU Medical USD 307.96M 8.23M Dec/2025
Intuitive Surgical USD 7.98B 1.05B Mar/2026
Masimo USD 124.6M 187.7M Mar/2026
Medtronic USD 1.15B 135M Dec/2025
Merit Medical Systems USD 488.08M 41.68M Mar/2026
Neogen USD 159.9M 14.56M Dec/2025
OraSure Technologies USD 176.96M 22.31M Mar/2026
Plus Therapeutics USD 3.02M 1.23M Mar/2026
Quidel USD 140.4M 29.4M Mar/2026
ResMed USD 1.66B 243.44M Mar/2026
STAAR Surgical USD 153.15M 23M Dec/2025
Steris USD 423.7M 104.5M Dec/2025
Stryker USD 2.88B 1.13B Mar/2026
Surmodics USD 36.11M 11.81M Sep/2024
Teleflex USD 309.41M 69.15M Mar/2026
Terumo JPY 217.16B 12.86B Sep/2025
Thermo Fisher Scientific USD 3.25B 6.6B Mar/2026
US Physical Therapy USD 28.44M 7.13M Mar/2026
Zimmer Biomet Holdings USD 424.2M 167.7M Mar/2026